“SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE”, Int. J. Pharm. Sci. Drug Res., vol. 9, no. 5, pp. 220–223, Sep. 2017, doi: 10.25004/IJPSDR.2017.090503.